HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
BC StageTimingPrefixVS ValueSet
When staging was done, relative to treatment events.
| Defining URL: | http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-StageTimingPrefixVS |
| Name: | StageTimingPrefixVS |
| Definition: | When staging was done, relative to treatment events. |
| Publisher: | The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC) |
| Source Resource | XML / JSON / Turtle |
This value set contains 4 concepts
Expansion based on http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-StageTimingPrefixCS version 0.1.0
All codes from system http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-StageTimingPrefixCS
| Code | Display | Definition |
| cli | Staging performed prior to surgery, based on evidence such as physical examination, imaging, and/or biopsy. | Staging performed prior to surgery, based on evidence such as physical examination, imaging, and/or biopsy. |
| path | Staging performed based on examination of tissue samples removed during surgery, in addition to physical examination and imaging. | Staging performed based on examination of tissue samples removed during surgery, in addition to physical examination and imaging. |
| postther_cli | Post-therapeutic (post-neoadjuvant) clinical staging based on clinical examination after the first treatment with systemic drugs or radiation, when no surgery has been performed. | Post-therapeutic (post-neoadjuvant) clinical staging based on clinical examination after the first treatment with systemic drugs or radiation, when no surgery has been performed. |
| postther_path | Post-therapeutic (post-neoadjuvant) pathologic staging, based on tissue samples removed during surgery after the first treatment with systemic drugs or radiation. | Post-therapeutic (post-neoadjuvant) pathologic staging, based on tissue samples removed during surgery after the first treatment with systemic drugs or radiation. |